Bladder Cancer Incidence and Mortality by Year, New York State Excl New York City, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 1,984 21.7 20.8-22.7 1,461 39.6 37.4-41.8 523 9.8 9.0-10.7 601 7.0 6.4-7.6 431 13.0 11.7-14.4 170 3.3 2.8-3.9
1977 2,023 21.8 20.9-22.8 1,476 38.8 36.7-40.9 547 10.3 9.5-11.2 599 6.9 6.4-7.5 419 12.6 11.3-13.9 180 3.5 3.0-4.0
1978 2,141 22.8 21.9-23.8 1,559 41.0 38.9-43.3 582 10.8 9.9-11.7 614 6.9 6.3-7.5 428 12.7 11.4-14.0 186 3.4 2.9-4.0
1979 2,166 22.7 21.7-23.6 1,622 42.1 40.0-44.3 544 9.8 8.9-10.6 602 6.7 6.2-7.3 403 11.7 10.6-13.0 199 3.7 3.2-4.2
1980 2,255 23.2 22.3-24.2 1,657 42.1 40.0-44.3 598 10.6 9.8-11.5 576 6.2 5.7-6.7 405 11.6 10.4-12.8 171 3.1 2.6-3.6
1981 2,207 22.4 21.5-23.4 1,633 41.1 39.0-43.2 574 10.1 9.3-10.9 632 6.8 6.2-7.3 450 12.9 11.7-14.2 182 3.2 2.8-3.7
1982 2,378 23.9 23.0-24.9 1,735 43.0 40.9-45.2 643 11.1 10.2-12.0 584 6.1 5.7-6.7 410 11.4 10.3-12.6 174 3.0 2.6-3.5
1983 2,307 22.9 22.0-23.9 1,715 42.4 40.3-44.6 592 10.1 9.3-10.9 582 6.1 5.6-6.6 419 12.0 10.8-13.2 163 2.8 2.3-3.2
1984 2,329 22.9 21.9-23.8 1,684 41.0 38.9-43.1 645 10.9 10.1-11.8 592 6.2 5.7-6.7 405 11.6 10.4-12.9 187 3.1 2.7-3.6
1985 2,446 23.9 22.9-24.8 1,780 42.9 40.9-45.1 666 11.2 10.4-12.1 581 5.9 5.5-6.4 396 10.8 9.7-12.0 185 3.1 2.7-3.6
1986 2,522 24.3 23.3-25.3 1,856 43.9 41.8-46.0 666 11.1 10.3-12.0 591 6.0 5.5-6.5 411 11.6 10.5-12.9 180 3.0 2.5-3.4
1987 2,374 22.6 21.7-23.6 1,703 39.8 37.9-41.8 671 11.0 10.1-11.8 544 5.4 5.0-5.9 363 9.8 8.8-10.9 181 2.9 2.5-3.4
1988 2,402 22.8 21.9-23.8 1,742 40.7 38.7-42.8 660 10.8 10.0-11.6 577 5.6 5.2-6.1 386 10.0 9.0-11.1 191 3.0 2.6-3.5
1989 2,468 23.1 22.2-24.1 1,803 41.7 39.7-43.7 665 10.7 9.9-11.5 563 5.5 5.0-5.9 403 10.7 9.6-11.8 160 2.5 2.1-2.9
1990 2,555 23.8 22.8-24.7 1,832 41.9 39.9-44.0 723 11.6 10.8-12.5 575 5.5 5.1-6.0 378 9.8 8.8-10.9 197 3.0 2.6-3.5
1991 2,517 23.0 22.1-24.0 1,827 41.0 39.1-43.0 690 10.8 10.0-11.7 568 5.3 4.9-5.8 392 9.9 8.9-11.0 176 2.7 2.3-3.1
1992 2,524 22.9 22.0-23.9 1,823 40.8 38.9-42.8 701 11.0 10.2-11.9 583 5.4 4.9-5.8 350 8.8 7.9-9.8 233 3.5 3.0-3.9
1993 2,688 24.1 23.2-25.0 1,879 41.0 39.2-43.0 809 12.5 11.6-13.3 586 5.3 4.9-5.8 390 9.8 8.8-10.8 196 2.9 2.5-3.3
1994 2,549 22.8 21.9-23.7 1,838 40.0 38.2-42.0 711 11.0 10.2-11.8 593 5.3 4.9-5.8 394 9.5 8.6-10.5 199 2.9 2.5-3.3
1995 2,714 24.1 23.2-25.0 1,911 41.1 39.3-43.1 803 12.3 11.4-13.2 563 5.0 4.6-5.4 372 8.8 7.9-9.8 191 2.8 2.4-3.2
1996 2,938 25.8 24.9-26.8 2,147 45.9 43.9-47.9 791 12.0 11.2-12.9 627 5.5 5.1-6.0 417 9.9 8.9-10.9 210 3.0 2.6-3.5
1997 3,068 26.7 25.8-27.7 2,208 46.6 44.6-48.6 860 12.9 12.0-13.8 641 5.6 5.1-6.0 427 9.7 8.8-10.7 214 3.0 2.6-3.5
1998 3,189 27.5 26.6-28.5 2,330 48.4 46.4-50.4 859 13.0 12.1-13.9 603 5.2 4.8-5.6 423 9.7 8.8-10.7 180 2.5 2.1-2.9
1999 3,217 27.5 26.5-28.4 2,326 47.6 45.7-49.6 891 13.2 12.3-14.1 610 5.2 4.8-5.6 419 9.4 8.5-10.4 191 2.6 2.2-3.0
2000 3,245 27.3 26.4-28.3 2,348 47.4 45.5-49.4 897 13.0 12.1-13.9 617 5.1 4.7-5.6 423 9.1 8.3-10.1 194 2.6 2.3-3.0
2001 3,244 27.0 26.1-28.0 2,377 47.7 45.7-49.6 867 12.5 11.7-13.4 632 5.2 4.8-5.6 442 9.6 8.7-10.5 190 2.5 2.2-2.9
2002 3,400 28.0 27.1-29.0 2,527 49.7 47.7-51.6 873 12.6 11.7-13.4 631 5.1 4.7-5.5 420 8.9 8.0-9.8 211 2.9 2.5-3.3
2003 3,468 28.3 27.3-29.2 2,560 49.2 47.3-51.2 908 12.9 12.1-13.8 589 4.7 4.3-5.1 396 8.2 7.4-9.1 193 2.5 2.2-2.9
2004 3,597 29.0 28.1-30.0 2,664 51.0 49.1-53.0 933 13.2 12.4-14.1 627 5.0 4.6-5.4 430 8.6 7.8-9.5 197 2.6 2.2-3.0
2005 3,630 29.0 28.1-30.0 2,675 50.5 48.6-52.5 955 13.3 12.5-14.2 592 4.6 4.2-5.0 398 8.0 7.2-8.8 194 2.5 2.1-2.9
2006 3,555 28.1 27.1-29.0 2,624 48.9 47.1-50.9 931 13.0 12.1-13.8 591 4.6 4.2-5.0 405 7.9 7.2-8.8 186 2.4 2.1-2.8
2007 3,546 27.7 26.8-28.6 2,618 47.8 46.0-49.7 928 12.9 12.1-13.8 677 5.1 4.8-5.6 476 9.1 8.3-10.0 201 2.5 2.2-2.9
2008 3,699 28.3 27.4-29.3 2,781 50.0 48.1-51.9 918 12.4 11.6-13.2 668 5.0 4.6-5.4 458 8.7 7.9-9.5 210 2.6 2.2-3.0
2009 3,747 28.3 27.4-29.2 2,803 49.5 47.6-51.4 944 12.5 11.7-13.4 674 5.0 4.6-5.4 508 9.4 8.6-10.3 166 2.0 1.7-2.4
2010 3,501 26.0 25.2-26.9 2,643 45.8 44.1-47.6 858 11.3 10.5-12.1 692 5.0 4.6-5.4 479 8.6 7.8-9.4 213 2.6 2.2-2.9
2011 3,817 28.2 27.3-29.1 2,854 48.5 46.7-50.3 963 12.8 12.0-13.6 648 4.6 4.2-5.0 456 8.1 7.4-8.9 192 2.3 2.0-2.6
2012 3,918 28.3 27.4-29.2 2,895 48.6 46.8-50.5 1,023 13.0 12.2-13.9 668 4.7 4.4-5.1 460 8.0 7.3-8.8 208 2.5 2.1-2.8
2013 3,951 28.3 27.4-29.2 2,949 49.0 47.2-50.8 1,002 12.7 11.9-13.6 680 4.7 4.4-5.1 489 8.4 7.6-9.1 191 2.2 1.9-2.6
2014 3,865 27.0 26.2-27.9 2,887 46.5 44.8-48.3 978 12.1 11.3-12.9 716 4.9 4.5-5.2 488 8.2 7.4-8.9 228 2.7 2.3-3.1
2015 3,771 26.1 25.3-27.0 2,806 44.4 42.8-46.1 965 12.1 11.3-12.9 669 4.5 4.2-4.9 460 7.5 6.8-8.2 209 2.5 2.1-2.8
2016 3,920 26.6 25.8-27.5 2,943 45.5 43.8-47.2 977 11.9 11.1-12.7 693 4.6 4.3-5.0 492 8.0 7.3-8.8 201 2.3 1.9-2.6
2017 3,878 26.0 25.1-26.8 2,915 44.6 43.0-46.3 963 11.5 10.8-12.3 673 4.4 4.0-4.7 463 7.4 6.7-8.1 210 2.3 2.0-2.6
2018 3,866 25.4 24.5-26.2 2,891 43.0 41.4-44.7 975 11.5 10.8-12.3 687 4.4 4.1-4.7 495 7.7 7.0-8.4 192 2.2 1.9-2.5
2019 3,880 25.1 24.3-25.9 2,909 42.5 40.9-44.1 971 11.4 10.6-12.1 624 3.9 3.6-4.3 451 6.9 6.3-7.6 173 1.9 1.6-2.2
2020 3,551 22.6 21.8-23.3 2,685 38.6 37.1-40.1 866 9.9 9.3-10.6 641 4.0 3.7-4.3 467 7.1 6.5-7.8 174 1.9 1.6-2.2

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.